We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byWinfred Lee Watson
Modified over 5 years ago
Survival after Sublobar Resection for Early-Stage Lung Cancer: Methodological Obstacles in Comparing the Efficacy to Lobectomy Emanuela Taioli, MD, PhD, Rowena Yip, MPH, Ingram Olkin, PhD, Andrea Wolf, MD, MPH, Daniel Nicastri, MD, Claudia Henschke, MD, PhD, David Yankelevitz, MD, Harvey Pass, MD, Raja M. Flores, MD Journal of Thoracic Oncology Volume 11, Issue 3, Pages (March 2016) DOI: /j.jtho Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Absolute difference in 5-year survival between lobectomy versus sublobectomy for stage I lung cancer from 1994 to 2014 (absolute numbers are reported in Table 1 under the 5-year survival column). Note: red dots denote studies on stage IA lung cancers; square dots denote the two propensity matched studies; the orange horizontal line marks the difference in survival reported by the only randomized clinical trial,1 for comparative purposes (stage was determined using radiography in the randomized trial). Journal of Thoracic Oncology , DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies Sai-Hong Ignatius Ou, MD,
Epidemiology of Environmental Exposure and Malignant Mesothelioma
Thomas J. Birdas, MD, Richard P. M
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer Raja Flores, MD, Thomas Bauer, MD, Ralph.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,
Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules Nasser K. Altorki, MD, Rowena Yip, MPH, Takaomi Hanaoka,
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901 Stephen L. Graziano,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD
Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,
Tetsuya Mitsudomi, MD, Hirohito Tada, MD Journal of Thoracic Oncology
Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H
Electronic Updates for JTO Readers
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review.
© 2024 SlidePlayer.com Inc. All rights reserved.